Rosucef T 250mg/31.25mg Injection
Marketer
Rosswelt Biosciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Rosucef T 250mg/31.25mg Injection
Cefuroxime and Sulbactam injection (250mg/31.25mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial growth and proliferation. Administration must be strictly under medical guidance; missed doses should be avoided, and the prescribed course should be completed regardless of symptom improvement. Premature cessation may compromise its effectiveness. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects warrant immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) require immediate emergency care. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, drowsiness or dizziness necessitates abstaining from driving. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Follow-up laboratory tests may be conducted to monitor treatment efficacy.
Primary Ingredients of Rosucef T 250mg/31.25mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Rosucef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Rosucef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Rosucef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Rosucef T 250mg/31.25mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Rosucef T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Rosucef T 250mg/31.25mg Injection, offer a powerful antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Rosucef T 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefuroxime (250mg/31.25mg) injection is typically deemed safe for pregnant individuals. Preclinical trials in animals have indicated minimal or no harm to the fetus; nevertheless, data from human studies remain scarce.
Breast feedingCAUTION
Cefuroxime axetil injection (250mg/31.25mg) necessitates careful consideration during lactation. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Cefuroxime and sulbactam injection (250mg/31.25mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Rosucef T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Cefuroxime and sulbactam injection (250mg/31.25mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage alteration for this injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Rosucef T 250mg/31.25mg Injection :
Should you inadvertently omit a scheduled dose of Rosucef T 250mg/31.25mg Injection, seek immediate medical advice.
Facts to Know About Rosucef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently